STAAR Surgical’s first quarter performance was met with a strong positive market reaction, reflecting the company’s progress ...

After one of the most contentious proxy battles in recent medical-device history, STAAR Surgical Company (NASDAQ:STAA) is beginning to prove that its standalone strategy can work. Last week, the Lake ...

Medical lens company STAAR Surgical (NASDAQ:STAA) reported Q1 CY2026 results , with sales up 120% year on year to $93.52 ...

STAAR Surgical (STAA) stock jumps as the company posts better-than-expected Q1 2026 results, prompting an upgrade from ...

STAAR Surgical Company delivered a robust 1Q26 beat, with revenue up 119% YoY to $93.5M and a swing to $5.2M net income. See ...

STAAR Surgical (STAA) stock price surged ~10% to $32.81 in just one day after a massive Q1 earnings beat, extending its monthly rally to around 20% as bulls cheered its strong China recovery and ...

A new Texas law will change the testing model in two years, but for now, here's what to know about spring 2026 standardized tests.

View STAAR Surgical Company STAA stock quote prices, financial information, real-time forecasts, and company news from CNN.

STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, announced that based on ...